PTC Therapeutics officer sells 52K company shares
PTC Therapeutics, Inc. reported that Chief Technical Operations Officer Neil Gregory Almstead sold a total of 52,003 shares of common stock in open‑market transactions on 2026-04-01 at prices around $69 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PTC Therapeutics, Inc. reported that Chief Technical Operations Officer Neil Gregory Almstead sold a total of 52,003 shares of common stock in open‑market transactions on 2026-04-01 at prices around $69 per share.
After these sales, he directly holds 60,137 shares of PTC Therapeutics common stock and indirectly holds 2,737 shares through his spouse. The filing notes that the transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 11, 2025.
Insider Trade Summary 10b5-1
Net Seller: 52,003 shares
Net Sell
4 txns
Insider
Almstead Neil Gregory
Role
CHIEF TECHNICAL OPS OFFICER
Sold
52,003 shs ($3.59M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 39,393 | $68.89 | $2.71M |
| Sale | Common Stock | 12,530 | $69.50 | $871K |
| Sale | Common Stock | 80 | $70.30 | $6K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 60,137 shares (Direct);
Common Stock — 2,737 shares (Indirect, By Spouse)
Footnotes (3)
- F1. This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.
- F2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.26 to $69.26 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.26 to $70.13 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Key Figures
Total shares sold: 52,003 shares
Sale price (block 1): $68.89 per share
Sale price (block 2): $69.50 per share
+4 more
7 metrics
Total shares sold
52,003 shares
Open-market sales on 2026-04-01
Sale price (block 1)
$68.89 per share
Weighted average price for 39,393-share sale
Sale price (block 2)
$69.50 per share
Weighted average price for 12,530-share sale
Sale price (block 3)
$70.30 per share
Price for 80-share sale
Direct holdings after sales
60,137 shares
Common stock directly owned post-transaction
Indirect holdings by spouse
2,737 shares
Common stock held indirectly through spouse
Rule 10b5-1 plan adoption date
November 11, 2025
Plan governing reported sales
Key Terms
Rule 10b5-1 plan, open-market sale, weighted average price, indirect ownership, +1 more
5 terms
Rule 10b5-1 plan regulatory
"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
open-market sale financial
"transaction_action: "open-market sale" with transaction code "S""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"This price represents the weighted average price of sale transactions that were executed in multiple trades"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirect ownership financial
"ownership_type: "indirect" and nature_of_ownership: "By Spouse""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PTC Therapeutics (PTCT) disclose for Neil Gregory Almstead?
PTC Therapeutics disclosed that Chief Technical Operations Officer Neil Gregory Almstead sold 52,003 shares of common stock in open‑market transactions on 2026-04-01. These trades were reported on a Form 4 insider filing and reflect routine reporting of executive share activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
